
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
.406 Ventures, founded 2005 in Boston. $1.4B+ AUM across 5 funds. Fund V: $265M (Feb 2024). 98 portfolio companies. Specializes in healthcare, data/AI, and cybersecurity. East Coast/Northeast focus. Led by Larry Begley, Liam Donohue, Maria Cirino. 27 team members.
Healthcare technology and digital health. Data and AI infrastructure. Cybersecurity and IT security. Enterprise SaaS and technology-enabled services.
98 portfolio companies. 1 unicorn, 2 IPOs, 36+ acquisitions. Notable exits: Veracode (CA Technologies), Carbon Black (VMware), Shazam (Apple), CloudHealth (VMware), Iora Health (One Medical/Amazon).
To approach .406 Ventures, founders should prepare a concise pitch that highlights their innovation in healthcare, data, or cybersecurity. Interested parties can submit their pitches through the firm's website at 406ventures.com or contact them directly via email at contact@406ventures.com.
In February 2024, .406 Ventures announced the closing of Fund V with a total of $265 million, further solidifying its position in the venture capital landscape. The firm has made 8 investments in the last 12 months, continuing its focus on early-stage companies in healthcare and technology sectors.
.406 Ventures invests in Seed and Series A stages.
Founders can pitch .406 Ventures through their website at 406ventures.com or via email at contact@406ventures.com.
.406 Ventures focuses on healthcare technology, data and AI, cybersecurity, fintech, and enterprise SaaS.
The firm typically writes checks ranging from $2 million to $10 million.
.406 Ventures primarily invests in startups located in the United States and the United Kingdom.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.